Synthego, a leading provider of CRISPR solutions, announces the successful closing of the acquisition of substantially all of its assets by funds managed by Perceptive Advisors, a leading life sciences investment firm. The transaction officially closed on July 18, 2025. The Perceptive funds’ acquisition reinforces Synthego’s mission to empower scientific discovery through advanced genomic engineering. Synthego will continue to manufacture its best-in-class guide RNA in Redwood City, California, ensuring this essential component is made in the USA and supports the development of CRISPR-based therapies for the global market.
Read the full article: Synthego Announces Successful Close of Acquisition by Perceptive Advisors //
Source: https://www.prnewswire.com/news-releases/synthego-announces-successful-close-of-acquisition-by-perceptive-advisors-302508990.html